Search academic texts

Information × Registration Number 0210U000920, 0110U000612 , R & D reports Title Investigation of Corvitin and Cvertin efficiency in prevention of cardiac hypertrophy and remodeling of different genesis popup.stage_title Head Moybenko Olexiy Olexiyovich, Registration Date 09-04-2010 Organization Bogomolets Institute of Physiology, National Academy of Sciences of Ukraine popup.description2 It was demonstrated that subsequent administration of Corvitin and Cvertin significantly improved haemodynamics, specifically, increased stroke volume and ejection fraction, cardiac output after coronary artery ligation and isoproterenol-induced cardiac injury, respectively. Subscription of quercetin-containing therapeutics had a pronounced effect on myocardial fibrosis limitation during myocardial infarction and isoproterenol-induced cardiac injury. Combined administration of Corvitin and Cvertin significantly upregulated brain natriuretic peptide expression that serves as one of the most powerful cardioprotective agents and its receptor expression after coronary artery ligation. Product Description popup.authors Гур’янова В.Л. Досенко В.Є. Каплінський С.П. Король М.О. Мойбенко О.О. Павлюченко В.Б. Тумановська Л.В. popup.nrat_date 2020-04-02 Close